rs763590950
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182919.4(TICAM1):āc.935A>Gā(p.Gln312Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,614,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_182919.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TICAM1 | NM_182919.4 | c.935A>G | p.Gln312Arg | missense_variant | 2/2 | ENST00000248244.6 | NP_891549.1 | |
TICAM1 | NM_001385678.1 | c.893A>G | p.Gln298Arg | missense_variant | 3/3 | NP_001372607.1 | ||
TICAM1 | NM_001385679.1 | c.800A>G | p.Gln267Arg | missense_variant | 2/2 | NP_001372608.1 | ||
TICAM1 | NM_001385680.1 | c.293A>G | p.Gln98Arg | missense_variant | 3/3 | NP_001372609.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TICAM1 | ENST00000248244.6 | c.935A>G | p.Gln312Arg | missense_variant | 2/2 | 1 | NM_182919.4 | ENSP00000248244 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152014Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000439 AC: 11AN: 250588Hom.: 0 AF XY: 0.0000590 AC XY: 8AN XY: 135648
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461868Hom.: 0 Cov.: 79 AF XY: 0.0000234 AC XY: 17AN XY: 727236
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74370
ClinVar
Submissions by phenotype
Herpes simplex encephalitis, susceptibility to, 4 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 04, 2022 | This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 312 of the TICAM1 protein (p.Gln312Arg). This variant is present in population databases (rs763590950, gnomAD 0.08%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 580273). This variant has not been reported in the literature in individuals affected with TICAM1-related conditions. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 13, 2021 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2021 | The c.935A>G (p.Q312R) alteration is located in exon 2 (coding exon 1) of the TICAM1 gene. This alteration results from a A to G substitution at nucleotide position 935, causing the glutamine (Q) at amino acid position 312 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at